Screener
Rein Therapeutics Inc. RNTX Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$0.10Beat by $0.07
EPS estimate-$0.17
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.10
Versus estimates
Diluted EPS
FAQ
- When did Rein Therapeutics Inc. report Q2 2026 earnings?
- Rein Therapeutics Inc. (RNTX) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Rein Therapeutics Inc.'s Q2 2026 revenue and EPS?
- Rein Therapeutics Inc. reported eps of $-0.10 for Q2 2026.
- Did Rein Therapeutics Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.17 by $0.07.
- How did Rein Therapeutics Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 64.3% from $-0.28.
- Where can I find Rein Therapeutics Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-350270) directly on SEC EDGAR. The filing index links above go to sec.gov.
